Tobias Weiglein
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
What can claims data tell us about risk factors and survival of patients with hepatocellular carcinoma? Insights from a German population-based study.
Journal: Frontiers in oncology
Published: June 20, 2025
Treatment gaps and survival outcomes of hepatocellular carcinoma: insights from a nationwide, claims-based study.
Journal: Therapeutic advances in medical oncology
Published: February 02, 2025
Acute Onset of Impaired Consciousness.
Journal: Deutsches Arzteblatt international
Published: December 18, 2023
Effect and sustainability of a stepwise implemented multidisciplinary antimicrobial stewardship programme in a university hospital emergency department.
Journal: JAC-antimicrobial resistance
Published: November 14, 2023
Follow-up lung ultrasound to monitor lung failure in COVID-19 ICU patients.
Journal: PloS one
Published: January 16, 2022
Budget Impact Analysis of CAR T-cell Therapy for Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma in Germany.
Journal: HemaSphere
Published: December 06, 2021
Accumulation of mutations in antibody and CD8 T cell epitopes in a B cell depleted lymphoma patient with chronic SARS-CoV-2 infection.
Journal: Nature communications
Published: August 31, 2021
The feasibility of electromagnetic sensing aided post pyloric feeding tube placement (CORTRAK) in patients with thrombocytopenia with or without anticoagulation on the intensive care unit.
Journal: JPEN. Journal of parenteral and enteral nutrition
Published: July 07, 2021
COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.
Journal: HemaSphere
Published: January 21, 2021
Correction: Onko-Nexus: A Bavarian "Caretaker Project" to Overcome the Interface Outpatient/Hospitalized Division - Three-Year Results
Journal: Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))
Published: August 04, 2020
Onko-Nexus: A Bavarian "Caretaker Project" to Overcome the Interface Outpatient/Hospitalized Division - Three-Year Results
Journal: Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))
Published: April 08, 2020
Temsirolimus acts as additive with bendamustine in aggressive lymphoma.
Journal: Annals of hematology
Published: October 15, 2015
Last Updated: 09/26/2026